CONNECT WITH US
HealthTech

HealthTech

Getinge hires president of acute care therapies

MedTech Dive logo

Published on

Add as a preferred source on Google
Getinge hires president of acute care therapies

Stacy Beske is joining Getinge from Philips and will take over the role on Dec. 1.

Previous title: Senior vice president, business unit leader for image guided therapy devices, Philips

Getinge has hired Philips executive Stacy Beske as president of acute care therapies, the company said Monday.

Beske will lead the unit after joining Getinge from Philips, where she works as the business unit leader for image guided therapy devices. Beske, who has a Ph.D. in cardiovascular physiology, previously worked at Medtronic for more than 18 years, serving in various roles, according to her LinkedIn profile.

Beske will take over the role Dec. 1. She will be replacing Elin Frostehav, who is leaving Getinge to be CEO of Vitrolife Group, a medtech company focused on reproductive health. Frostehav will remain at Getinge for an undisclosed length of time to ensure a smooth transition.

Beske has “a strong track record of leading complex businesses and transformations,” Getinge CEO Mattias Perjo said in a statement. That experience, plus Beske’s history of building high-performing teams, will be valuable to Getinge as it strengthens its acute care therapies unit, the CEO added.

The acute care therapies unit sells products such as the extracorporeal life support device Cardiohelp II and the endoscopic vessel harvesting system Vasoview Hemopro 2. Physicians use the technologies to treat patients with cardiogenic shock, acute respiratory distress syndrome and other life-threatening conditions.

The unit is central to Getinge’s business, accounting for more than half of the company’s net sales over the first nine months of the year.


Source link
Related Topics:HealthTech

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.